BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  BeyondSpring Announces the First Patient Enrolled in China in its Global Phase II/III Trial with Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia

  The enrollment took place at the Harbin Medical University Cancer Hospital in Harbin, China.

  October 26, 2017

   · 

  4 min read
• Business

  Agenus to Report Third Quarter 2017 Financial Results on November 7, 2017 and Host Conference Call and Webcast

  Agenus will release its third quarter 2017 financial results before the market opens on Tuesday, November 7, 2017.

  October 26, 2017

   · 

  2 min read
• Business

  Inivata Announces World-Leading Scientific Advisory Board

  October 26, 2017

   · 

  4 min read
• BioMidwest

  Myriad’s EndoPredict (EPclin) Shown in Second Study to be More Effective than Oncotype DX (RS) in Women with Intermediate Risk of Breast Cancer Recurrence

  The study found that EndoPredict (EPclin) was superior to the first-generation Oncotype DX Breast Recurrence Score (RS) in predicting breast cancer recurrence in women determined to be at intermediate clinical risk by Nottingham Prognostic Index.

  October 26, 2017

   · 

  8 min read
• Business

  Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33%

  The Company will host a conference call to discuss the results on Thursday, October 26, 2017, at 8:00 a.m. EDT.

  October 26, 2017

   · 

  8 min read
• Business

  ZIOPHARM Oncology to Host Third-Quarter 2017 Financial Results and Corporate Update Conference Call on November 6, 2017 at 4:30 p.m. ET

  The call can be accessed by dialing 1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international).

  October 26, 2017

   · 

  1 min read
• Genetown

  Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock

  The Company has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock

  October 26, 2017

   · 

  4 min read
• Drug Development

  MediciNova Announces Positive Top-Line Results from the SPRINT-MS Phase IIb Trial of MN-166 (ibudilast) in Progressive MS: Achieved Both Primary Endpoints including a Significant Reduction in Whole Brain Atrophy and Safety and Tolerability

  The study was conducted by the NeuroNEXT network with funding from the NIH National Institute of Neurological Diseases and Stroke, the National Multiple Sclerosis Society, and MediciNova.

  October 26, 2017

   · 

  9 min read
• Business

  Sonoma Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results and Conference Call

  The earnings release will be followed by a conference call at 1:30 p.m. PST on November 9, 2017, to discuss fiscal second quarter results.

  October 26, 2017

   · 

  1 min read
• Business

  Catalyst Biosciences Announces the Appointment of Industry Veteran Andrea Hunt to its Board of Directors

  Ms. Hunt was most recently vice president, New Product Gene Therapy, Neuroscience, Oncology, Ophthalmology at Shire.

  October 26, 2017

   · 

  3 min read